Keywords

• 656247-18-6
• Nintedanib Esylate
• Nintedanib

Quick Details

• ProName: Supply 99% CAS 656247-18-6 Nintedanib ...
• CasNo: 656247-18-6
• Molecular Formula: C31H33N5O4.C2H6O3S
• Appearance: White powder
• Application: Nintedanib is the first approved drug ...
• DeliveryTime: 3-5 days
• PackAge: 1-5kg Bag 5-25kg Carton 25kg Drum
• Port: Shanghai,China
• ProductionCapacity: 50 Kilogram/Month
• Purity: 99%
• Storage: Cool Dry Place
• Transportation: 25KG/drum,or according to your require...
• LimitNum: 100 Gram
• Related Substances: ≥98%
• Residue on Ignition: ≤0.1%
• Heavy Metal: ≤0.1%
• Valid Period: 2 years
• Grade Standard: Medicine Grade
• Test Method: HPLC UV
• Place of Origin: Xi‘an,China
• MF: C31H33N5O4.C2H6O3S
• Standard: USP/EP
• Shelf Life: 2 Years
• Storage: Cool Dried Storage
• Package: 1kg/Bag 25kg/Drum

Superiority

We promise our customer following items:

1.Support product customization:

We can provide OEM&ODM , Because we have a professional design team


2.Reasonable price:
We provide high quality products with competitive price in china,

3.Low moq:
No worry about the low moq, our moq is 1 gram or lower.

3.Good and efficient service,Fast Delivery
Fast respond save client's time, we promise to reply inquiry in 24 hours including holidays and send quotation sheet and other documents in 48 hours.

4.Super-good quality
We have strict quality control system .Good reputation in Market , And have the Third party test report is available


Pls contact us

If you have any further questions or need a sample,Please do not hesitate to contact us.

Xi'an Julong Bio-Tech Co., Ltd.

Details

                                                                                       Supply 99% CAS 656247-18-6 Nintedanib Esylate Powder

Nintedanib is the first approved drug for the management of idiopathic pulmonary fibrosis (IPF), a rare but often fatal lung disease. Nintedanib 
is believed to exert its mechanism of action by inhibiting multiple receptor tyrosine kinases, including those that have been implicated in the
pathogenesis of IPF (i.e., fibroblast growth factor receptor, platelet-derived growth factor receptor, and vascular endothelial growth factor
receptor). Nintedanib also inhibits nonreceptor tyrosine kinases, although the contribution of this inhibition in the efficacy of the drug is unknown.



Julong Bio-Tech Co., Ltd. is located in Xi'an City, Shaanxi Province, China. It is a biotechnology enterprise engaged in the research,
development,production and sales of animal and plant extracts, cosmetics, pharmaceutical raw materials and intermediates. The company has
complete experimental facilities. And advanced testing instruments  ensure the stability of product quality from all aspects. The company has
a complete sales service system, the products are exported to countries all over the world, and have won a good international reputation with
excellent quality and excellent service.

The company has been adhering to the basic principles of "integrity, quality, service, and win-win" to serve customers, constantly strict
requirements, set goals, and implement win-win development.